Arthroscopic Knee Surgery vs. PRP Injections for Knee Arthritis
- 2 days ago
- 4 min read
By Dr. Jeffrey Peng, MD · Published March 6, 2026 · 6 min read
Watch the Full Video
If you are dealing with knee osteoarthritis and have been told that arthroscopic surgery might help, you may be wondering how it compares to platelet-rich plasma (PRP) injections. Head-to-head trials comparing PRP to placebo, hyaluronic acid, and cortisone injections have consistently shown that PRP produces superior and more sustained symptom relief. But how does PRP stack up against surgery? A randomized controlled trial published in the Malaysian Orthopaedic Journal provides some compelling answers.
What Is Knee Osteoarthritis?
Knee osteoarthritis results from the progressive wear and loss of articular cartilage — the smooth, protective tissue that allows bones to glide against one another. As this cartilage deteriorates, the once-smooth surfaces become rough and irregular. Damaged cartilage can cause rubbing, catching, and even mechanical symptoms such as locking and clicking within the joint. The end result is a cycle of degeneration, inflammation, and pain that can significantly limit daily function.
Why Do Some Surgeons Recommend Arthroscopic Surgery?
Arthroscopic surgery for knee osteoarthritis involves using minimally invasive instruments to enter the joint, remove loose tissue and cartilage fragments, and smooth out irregular surfaces. The theory is that by cleaning up the joint and restoring a smoother articular surface, symptoms related to osteoarthritis — particularly mechanical catching and pain — should improve.
PRP vs. Arthroscopic Surgery: What Does the Research Show?
A randomized controlled trial by Singh et al. (2022) directly compared a single PRP injection to arthroscopic knee surgery in 70 patients with Kellgren-Lawrence grade 2 to 3 (mild to moderate) knee osteoarthritis between the ages of 40 and 60. All participants had already failed an initial course of conservative treatment.
In the PRP group, 20 cc of blood was drawn and concentrated to approximately 4 to 5 cc, yielding about 4 billion platelets. No activating agent was used, and injections were performed using a landmark-based technique rather than ultrasound guidance.
In the arthroscopic surgery group, the procedure included microfracture of the subchondral bone to stimulate bleeding, debridement of damaged cartilage and meniscal tissue, removal of inflamed synovial membranes, and irrigation of the joint with sterile solution.
The results were clear. Both treatments improved function and reduced pain, but PRP consistently outperformed arthroscopic surgery at every follow-up interval. On the WOMAC osteoarthritis index, the PRP group had significantly better functional scores at three, six, and nine months. Pain scores measured by the visual analog scale followed the same pattern — the arthroscopic surgery group had worse outcomes at every time point.
By nine months, the PRP group maintained a 9 percent reduction in functional scores compared to 0 percent in the surgery group. Pain scores showed an 8 percent sustained reduction with PRP versus only 3 percent with surgery.
Why PRP May Be the Better Choice
This study adds to a growing body of evidence that PRP is effective for symptomatic knee osteoarthritis. Not only did PRP produce better functional improvements and pain scores, it is also far easier to administer and carries substantially lower risk. A PRP injection involves a simple blood draw and a quick in-office procedure — patients walk in, walk out, and the entire process takes about 40 minutes.
Arthroscopic surgery, on the other hand, carries inherent surgical risks including infection, blood clots, and other complications, along with the need for postoperative rehabilitation and downtime. Perhaps more concerning, whatever tissue is removed during surgery is gone permanently. Multiple studies have demonstrated that removing meniscal tissue increases the risk of accelerated wear and progression of osteoarthritis over time.
If you are considering treatment options for knee osteoarthritis, I encourage you to schedule a consultation to discuss whether PRP therapy may be right for you.
Could PRP Results Have Been Even Better?
There are reasons to believe that the PRP results in this trial may actually underestimate the treatment’s potential. The study used a 20 cc blood draw yielding approximately 4 billion platelets. In my practice, higher-quality preparation kits can process 50 to 60 cc of blood, producing 8 to 10 billion platelets.
Research by Bansal et al. (2021) published in Scientific Reports suggests that administering approximately 10 billion platelets results in even greater functional improvements and sustained pain relief out to one year. The Singh et al. trial found that a single lower-dose PRP injection of 4 billion platelets provided pain relief for less than nine months — raising the question of whether a higher platelet concentration could extend that benefit significantly.
Additionally, the PRP injections in this study were administered using a landmark-based technique. Landmark-based knee injections have accuracy rates as low as 55 percent, whereas ultrasound-guided injections achieve accuracy between 96 and 100 percent. It is worth considering what kind of results might have been observed if the researchers had used a higher platelet dose with ultrasound guidance.
Even with these limitations, PRP still outperformed arthroscopic surgery — a finding that speaks to the robustness of PRP as a treatment for knee osteoarthritis.
References
1. Singh N, Trivedi V, Kumar V, et al. A Comparative Study of Osteoarthritis Knee Arthroscopy versus Intra-Articular Platelet Rich Plasma Injection: A Randomised Study. Malaysian Orthopaedic Journal. 2022;16(2):31-40. doi:10.5704/MOJ.2207.004
2. Bansal H, Leon J, Pont JL, et al. Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: Correct dose critical for long term clinical efficacy. Scientific Reports. 2021;11(1):3971. doi:10.1038/s41598-021-83025-2
Medical Disclaimer: This content is for educational purposes only and does not substitute for the medical advice of a physician. Always consult your healthcare provider before beginning any new treatment program. The information presented reflects the opinion of Dr. Jeffrey Peng and does not represent the views of his employers or affiliated hospital systems.
Comments